These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6339110)

  • 1. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of complex ventricular arrhythmias by oral flecainide.
    Duran D; Platia EV; Griffith LS; Adhar G; Reid PR
    Clin Pharmacol Ther; 1982 Nov; 32(5):554-61. PubMed ID: 7127996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide: a new class Ic antidysrhythmic.
    Smith GH
    Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
    Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM
    J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of a slow-release quinidine preparation and flecainide administered in 2 daily doses for the treatment of extrasystole].
    Clémenty J; Castagne D; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1984 Oct; 33(6):401-5. PubMed ID: 6208841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias.
    Panidis I; Morganroth J
    J Clin Pharmacol; 1982; 22(8-9):379-84. PubMed ID: 6752212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.